Position history for FARALLON CAPITAL MANAGEMENT LLC's holdings in PROTAGONIST THERAPEUTICS INC
FARALLON CAPITAL MANAGEMENT LLC holds 6.1M shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $536.6M as of 2025-Q4. The position was decreased (-0.8% shares). PTGX represents 2.5% of FARALLON CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$536.6M
Current Shares
6.1M
Total Value Change
+$334.2M
Total Shares Change
+303,233
Other major holders of PTGX: BNP PARIBAS FINANCIAL MARKETS, UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC, CAPITAL FUND MANAGEMENT S.A.
Decreased |
| 6.1M |
-0.8% |
| $536.6M |
| 2.5% |
| $87.26 |
0 |
| 2025-Q3 | Increased | 6.2M | +0.4% | $411.6M | 1.7% | $65.14 | 49 |
| 2025-Q2 | Increased | 6.2M | +1.1% | $341.1M | 1.5% | $55.69 | 49 |
| 2025-Q1 | Increased | 6.1M | +3.0% | $295.3M | 1.6% | $48.88 | 50 |
| 2024-Q4 | Increased | 5.9M | +1.2% | $228.9M | 1.2% | $38.51 | 49 |
| 2024-Q3 | Increased | 5.9M | +0.3% | $263.7M | 1.3% | $44.56 | 49 |
| 2024-Q2 | Increased | 5.8M | +1.8% | $202.4M | 1.0% | $34.65 | 44 |